‘The sleep­ing gi­ant is wak­ing up’: FTC rais­es the pres­sure on phar­ma deal­mak­ing

In 2020, the Fed­er­al Trade Com­mis­sion nar­row­ly ap­proved Ab­b­Vie’s $65 bil­lion takeover of Al­ler­gan. It’s un­like­ly the an­titrust en­forcer would ap­prove such a deal to­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER